Polyrizon Ltd.’s Quiet Period Will Expire on December 9th (NASDAQ:PLRZ)

Polyrizon’s (NASDAQ:PLRZGet Free Report) quiet period will end on Monday, December 9th. Polyrizon had issued 958,903 shares in its public offering on October 29th. The total size of the offering was $4,199,995 based on an initial share price of $4.38. During Polyrizon’s quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Polyrizon Trading Up 3.1 %

Shares of PLRZ opened at $0.94 on Monday. Polyrizon has a 52-week low of $0.77 and a 52-week high of $1.97.

About Polyrizon

(Get Free Report)

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Featured Stories

Receive News & Ratings for Polyrizon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polyrizon and related companies with MarketBeat.com's FREE daily email newsletter.